To investigate the current genotypes of circulating human adenovirus (HAdV) strains, we HAdV-7 alone had an increased frequency of severe pneumonia involvement (11.6% vs 32.4%; P = 0.031), higher intensive care unit admission rates (7.0% vs 26.5%; P = 0.019), and a longer length of hospital stay (P = 0.03). Mixed infections in younger children were associated with a longer hospital stay (P = 0.023). Our results demonstrate the recent changes in the trends of circulating HAdV genotypes associated with ALRTIs in Hunan China.
To date, 79 HAdV types have been identified and are classified into seven species (A-G). [8] [9] [10] [11] [12] [13] [14] HAdV types 1 to 7 account for approximately 80% of all HAdV-infected cases in children. 5, 6, 15, 16 HAdV-3 and HAdV-7 are closely associated with LRTIs. 5, 6, 15, 16 HAdV-7 may lead to severe respiratory tract infections and HAdV-7 infection is associated with a high incidence of death and severe sequelae. [16] [17] [18] The dominant type and detection rate of HAdV vary in different countries and eras. Epidemic outbreaks of HAdV-3 and HAdV-7
infections occurred in children during the 1950s and 1960s in China. 16, 17 HAdV-3 and HAdV-7 infections are currently the most severe infections in Northern China with mortality rates of 16.6% to 33.3%. The incidence and severity of HAdV infections have decreased gradually since the 1980s, 16, 17, 19, 20 although an epidemic outbreak of HAdV-7 infection occurred in a northern city of Shanxi Province (China) in January 2009. 19 Subsequently, an epidemic outbreak of HAdV-55 infection, which was confirmed to be an intertypic recombinant virus according to complete genomic sequencing and was designated as a new genotype after bioinformatics analysis, was detected in January 2013 in China. 21, 22 Currently, the molecular and clinical characterization of HAdV infection in Chinese children is limited. Therefore, the current study aimed to explore the molecular epidemiology and clinical features of HAdV infection in hospitalized children with acute lower respiratory tract infections (ALRTIs) in Hunan, China.
| MATERIALS AND METHODS

| Ethics statement
The study protocol was approved by the Ethical Review Committee of Hunan People's Hospital. The parents or guardians of all the participants in this cooperative study provided written informed consent.
| Patients and sample collection
Respiratory virus surveillance was performed in 4751 patients who were enrolled from September 2007 to March 2014 at Hunan People's
Hospital. The patients in this study were children diagnosed with ALRTIs (including pneumonia, acute bronchitis, and bronchiolitis).
ALRTIs were diagnosed on the basis of clinical and radiologic findings.
Enrollment of children in the study followed the diagnosis of dominant symptoms of an acute or worsening cough or a clinical presentation that suggested an LRTI with a duration of less than or equal to 28 days. The age of the children in our study ranged from 1 day to 14 years.
All nasopharyngeal aspirate (NPA) samples were collected 1 to 3 days after admission to the hospital. Approximately 1 to 2 mL of deep NPA samples was obtained using a disposable sterile suction tube that was inserted 7 to 8 cm into the throat via the nose. NPA samples were then transferred to a sterile collection tube after normal saline was 
| Data collection
The general demographics, including age, sex, and NPA sample collection time, were recorded. The details of the clinical findings and disease severity were obtained from the medical records after the patients' discharge from the hospital. Patients coinfected with bacteria, mycoplasma, and chlamydia were excluded from the statistical data of the clinical profiles of HAdV infection cases.
| DNA/RNA extraction
Viral DNA and RNA were extracted from 140 μL of each NPA sample using a QIAamp Viral DNA and RNA Mini Kit (Qiagen, Shanghai, China) according to the manufacturer's protocol.
Random hexamer primers and the Superscript II RH-reverse transcriptase (Invitrogen, Carlsbad, CA) were used to synthesize complementary DNA (cDNA).
| HAdV detection
Nested polymerase chain reaction (PCR) and DNA sequencing of the HAdV hexon gene HVR1-6 were used in the current study as they are more rapid and efficient compared with classical serologic testing. 23, 24 The AdhexF1/R1 and AdhexF2/R2 primer pairs 24 were used to amplify a 688-to 821-bp fragment of the hexon gene. The PCR program used was 94°C for 3 minutes, followed by 35 cycles of 94°C for 30 seconds, 52°C for 30 seconds, 72°C for 60 seconds, and a final 8-minute extension at 72°C.
| Screening for other respiratory viruses
From September 2007 to March 2012, 3495 NPA samples were randomly collected from 3495 children with ALRTI. In addition to
HAdVs, the samples were also screened for human respiratory syncytial virus (HRSV), human metapneumovirus (HMPV), influenza viruses A and B (IFVA and IFVB), parainfluenza virus types 1 to 3 (PIV1-3), human rhinoviruses (HRVs), human coronaviruses (HCoV-NL63 and HCoV-HKU1), and human bocavirus (HBoV) using PCR as described in previous studies. 25, 26 From April 2012 to March 2014, 1256 NPA samples were collected, and 11 respiratory viruses were detected by real-time PCR as described previously [27] [28] [29] ( Figure 1 ).
| Nucleotide sequence analysis
All of the amplification products of HAdV were sent to Beijing Tianyi 
| Statistical analysis
Normally distributed continuous data are presented as the mean ± SD and were analyzed using the Student t test or ANOVA followed Figure 2 ). There were 197 patients with acute bronchitis, 1003 with bronchiolitis, and 3551 with pneumonia.
| HAdV types
Of the 4751 patients, 447 patients were HAdV positive and the detection rate was 9.4%. Infections of other types were only sporadic (Supporting Information Table 1 ).
| Characteristics of patients infected with HAdV
The age of the 447 patients with HAdV infection (male:female, 1.55:1)
ranged from 1 day to 144 months (mean, 24.2 ± 21.3 months). Of the 447 patients, 93.3% (417 of 447) were younger than 5 years of age and 71.6% of patients (320 of 447) were younger than 3 years of age, including 13 newborns. The HAdV infection rates varied significantly among the different age groups. The HAdV detection rate was the highest in 3 to 4 years old children and was lowest in children less than 6 months old (χ 2 = 76.87; P = 0.000; Supporting Information Figure 2 ).
HAdV-7 showed the highest detection rate among 4 to 5 years old children (χ 2 = 14.28; P = 0.022). HAdV-3 was the predominant HAdV infection type in children aged 3 to 4 years old (χ 2 = 51.18; P = 0.000).
HAdV-1 was the most common type in children aged 2 to 3 years old (χ 2 = 22.01; P = 0.010; Supporting Information Figure 3 ). The detection rates of the other types showed no clear age distribution (data not shown). 
| Epidemiology of HAdV infection
The seasonal and monthly distribution of HAdV infection is shown in HAdV-2 showed no obvious seasonal distribution. Tables 1 and 2 . The mean age of these 279 patients was 20 months old, and most patients were aged 1-to 2-year old (P = 0.013), with a sex ratio of 1.68:1 (male:female). The 279 patients included 237
| Clinical profile of HAdV infection
(85.0%) cases diagnosed with pneumonia, 18 (6.5%) cases diagnosed with bronchiolitis, and 24 (8.6%) cases diagnosed with bronchitis.
Fever was one of the most common symptoms after HAdV infection (77.1%, 215 of 279), and 48.4% (135 of 279) of patients had a temperature greater than 39°C. The mean duration of fever was 6 days, and 22.6% of patients had a fever lasting more than 1 week. Extrapulmonary manifestations included diarrhea (12.2%), vomiting (9.7%), neurological symptoms (7.2%), and rash (9.0%).
Of the 279 HAdV-infected patients, 106 (38.0%) had a single than the 11.6% (5 of 43 patients) of patients infected with the single HAdV-3 (P = 0.031; Table 4 ). Pneumonia consolidation and admission to the ICU were more common in patients with a single HAdV-7 infection (P = 0.013 and 0.019, respectively; Table 4 ). HAdV-7 infection resulted in patients having a longer hospital stay compared with that of patients infected with HAdV-3 (P = 0.03; Table 4 ).
| Other respiratory viruses
The Hangzhou (China) 30 and in 2011 in Taiwan. 31 Age is a known risk factor for LRTIs caused by HAdV. Most studies have indicated that HAdV is the major pathogen that causes
LRTIs in children aged 6 months to 5 years old. 32 Severe LRTIs often occur in infants aged 6 to 24 months old. Children less than 6 months old often show immunity to HAdV because of maternal antibodies. 3, 5, 6, 16, 20 This study also indicated that the majority of HAdV infections occurred in patients from 6 months to 5 years old, whereas the HAdV detection rate was higher in children aged 3 to 4 years.
The reason for this difference may be the close contact of kindergarteners between the ages of 3 to 4 years. However, HAdV infection was most common in children aged 0 to 12 months old in Southern Palestine 33 and 6 to 23 months old in Korea. 6 HAdV infection was sporadically found throughout the year, and its incidence was relatively higher in winter and spring. 6, 16, 20 However, in the current study, the highest HAdV detection rate
T A B L E 4 Demographic data of and outcome from hospitalized children infected with single HAdV-3 infection and HAdV-7 infection, single infection and coinfection
Single infection, n = 106, % Coinfection, n = 173, % P Single HAdV-3, n = 43, % Single HAdV-7, n = 34, % P HAdV infection was more frequent in males. 23 In this study, the 14 HAdV types were not evenly distributed during the study period. The distribution of HAdV types attained epidemic proportions, lasting 2 or 3 years in each cycle. 6, [34] [35] [36] HAdV-3 and HAdV-7 infections were the major prevalent HAdV infections among hospitalized children in Hunan (Southern China), similar to reports from Korea, 6 Argentina, 34 and Chongqing (China), 15, 16 but in contrast to reports from Malaysia, 37 Israel, 38 and Hong Kong. 5 In the current study, HAdV-3 infection epidemics were sustained for three years (2008) (2009) (2010) 39 By contrast, HAdV-7 infection is a major cause of LRTIs in children in China. 32 There was a high frequency of infection of HAdV-7 and HAdV-3 in pediatric pneumonia in Chongqing and Beijing, and HAdV-7 infection was associated with a higher incidence of severe pneumonia, 15, 40 which reinforces the findings of the current study.
HAdV-4 and HAdV-14 were the most common HAdV types associated with fever and respiratory infection among US military recruits, whereas they were uncommon in children with ALRTIs. 23 In HAdV-4 and HAdV-14. 15, 16 In the current study, 13 patients were infected with HAdV-4 and 6 patients were infected HAdV-14, which accounted for 2.9% and 1.3% of all patients infected with HAdVs, respectively. Cases of infections with HAdV-21, HAdV-37, HAdV-57, and HAdV-41 were rarely observed in children, 39 which was consistent with the current study.
Gene recombination plays an important role in the molecular evolution of HAdV and can lead to a novel type with epidemic outbreaks or dominant substitutions, such as HAdV-55. HAdV-55 is an intertypic recombinant virus of HAdV-11 and HAdV-14 and was recently described by complete genomic sequencing and designated as a new genotype after bioinformatics analysis. 22 We also found that The most common clinical ALRTI diagnosis was pneumonia (85.0%), followed by bronchitis and bronchiolitis. Most patients showed mild symptoms with good prognosis. Fever and cough were the most common manifestations of HAdV infection, which was consistent with previous studies. 6 HAdV-7 infection was associated with a higher fatality rate than HAdV-3 infection, which was consistent with previous reports. [17] [18] [19] [20] HAdV infection, particularly HAdV-7 infection, was strongly associated with severe morbidity, including required supplemental oxygen, an increased ICU stay, and a relatively longer hospitalization. 6, [15] [16] [17] [18] In this surveillance study, patients with HAdV-7 infection alone presented more severe pneumonia, relatively longer hospital stay, and more frequent transfer to the ICU compared with those in patients with HAdV-3 infection alone (all P < 0.05).
The rate of coinfection by HAdV and other respiratory viruses is high in patients with HAdV infection. 41, 42 We found that the rate of coinfection of HAdV and other respiratory viruses was 62.0% (173 of 279), which was similar to a report from Israel. 41 Comparative studies This study has several limitations. First, it was a single-center study and the results may not be generalized to other settings.
Second, our experiments did not determine the severity of other confounding factors, such as virus combinations, that could affect outcomes. Further, this study may also suffer from a selection bias as it did not include patients who consulted outpatient departments.
Additional multicenter studies are needed to establish the epidemiology of HAdV.
In conclusion, this study revealed the HAdV types and epidemiology of HAdV among hospitalized children in Hunan 
